Top Markets
#1 Siacoin Siacoin +33.47%
#2 The Bitcoin Bull The Bitcoin Bull +28.52%
#3 DogBull DogBull +26.50%
#4 Merlin's Seal BTC Merlin's Seal BTC +25.80%
#5 Cash Cat Cash Cat +21.23%
#6 Pons Pons +15.87%
#7 MarsCoin MarsCoin +12.84%
#8 Cryptopia Cryptopia +10.93%
#9 0G 0G +10.17%
#10 Useless Coin Useless Coin +7.81%
Coin of the day
Siacoin Siacoin
Settings
Language
ENGLISH
Currency
USD
Theme
Shandong Sito Bio-technology Co., Ltd. Shandong Sito Bio-technology Co., Ltd.

Shandong Sito Bio-technology Co., Ltd.

300583
Rank in Stocks #14491
Shandong Sito Bio-technology Co., Ltd. researches, develops, and produces... Shandong Sito Bio-technology Co., Ltd. researches, develops, and produces steroid biomedicine intermediates. Its products include 9a-hydroxyandrost, 17a-hydroxyprogesterone, 17a-hydroxy progesterone derivatives, anecort acetate, neomycin sulfate, progesterone intermediate, tylvalosin tartrate, tetraene acetate, androstenedione, bisnoralcohol, norandrostenedione, ethylene deltenone, 16ß and 16a methyl epoxide, and hexahydro-3a-methyl, as well as androsta-1,4-diene-3,17-dione and estra-4,9-diene-3,17-dione. Shandong Sito Bio-technology Co., Ltd. was founded in 2002 and is based in Heze, China.
Share Price
$2.17
Market Cap
$411.81M
Change (1 day)
1.84%
Change (1 year)
-6.47%
Country
CN
Trade Shandong Sito Bio-technology Co., Ltd. (300583)

Category

Healthcare
Revenue for Shandong Sito Bio-technology Co., Ltd. (300583)
Revenue in Sep 2026 TTM: 0
According to Shandong Sito Bio-technology Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Shandong Sito Bio-technology Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US